Security key
80401L803
Satellos Bioscience Inc. - Common Shares (MSLE)
CUSIP: 80401L803
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 7,597,066
- Total 13F value
- $42,791,195
- Share change
- +7,597,066
- SEC-reported price per share
- $5.63
- Number of holders
- 31
- Value change
- +$42,791,195
- Number of buys
- 31
- Shares outstanding
- 15,420,422
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
31
Top holders
10
MSLE full security history
Ownership snapshot
Full 13F holder table
Satellos Bioscience Inc. SEC filings
Satellos Bioscience Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 80401L803
Recent filing periods:
Ownership snapshot
Top reported holders of MSLE - Satellos Bioscience Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Qiming U.S. Healthcare Fu...
Disclosed value leader
Qiming U.S. Healthcare Fu...
Comparable rows
2/2
Latest evidence
31 Mar 2026
13D/G
Lead comparable stake: 8.3%
13D/G row: Qiming U.S. Healthcare Fund III, L.P.
Quick read
Qiming U.S. Healthcare Fund III, L.P. leads the comparable SEC ownership view at 8.3%.
2 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Qiming U.S. Healthcare Fund III, L.P.'s linked filing trail.
Comparable ownership
Top 2
Qiming U.S. Healthcare Fund III, ...
8.3%
Brian Matthew Bloom
7.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. |
13D/G
|
8.3%
|
$9,713,658
1,725,247 shares
|
$0 | 31 Mar 2026 |
| Brian Matthew Bloom |
13D/G
|
7.4%
|
$6,381,048
1,133,401 shares
|
$0 | 06 Feb 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
7,597,066
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
31
Q1 2026 holders
31
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend